These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9490358)

  • 21. Ion channels as targets for treatment of gastrointestinal motility disorders.
    Farrugia G
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():135. PubMed ID: 18924455
    [No Abstract]   [Full Text] [Related]  

  • 22. New vistas on gastrointestinal motility: from physiology to therapy an international symposium in Rome.
    Currò D; Holzer P
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():1-2. PubMed ID: 18924439
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA cautions breast-feeding moms.
    FDA Consum; 2004; 38(5):6. PubMed ID: 15595135
    [No Abstract]   [Full Text] [Related]  

  • 24. Domperidone in Parkinson's disease: a perilous arrhythmogenic or the gold standard?
    Lertxundi U; Domingo-Echaburu S; Soraluce A; García M; Ruiz-Osante B; Aguirre C
    Curr Drug Saf; 2013 Feb; 8(1):63-8. PubMed ID: 23656449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The enteric nervous system].
    Hansen MB
    Ugeskr Laeger; 2003 Oct; 165(43):4097-101. PubMed ID: 14619057
    [No Abstract]   [Full Text] [Related]  

  • 26. Gastrointestinal receptors and drugs in motility disorders.
    Ruoff HJ; Fladung B; Demol P; Weihrauch TR
    Digestion; 1991; 48(1):1-17. PubMed ID: 1651261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Methochlopramide. Pharmacological, radiological and clinical study].
    Meirelles Filho Jde S; de Melo e Souza L; Ramos L; Pontes JF
    Hospital (Rio J); 1966 Oct; 70(4):883-98. PubMed ID: 5301488
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of gastro-intestinal complaints accompanying menopause with Motilium film-coated tablet.
    Huber G
    Ther Hung; 1987; 35(4):227-31. PubMed ID: 3447309
    [No Abstract]   [Full Text] [Related]  

  • 29. Potential of ghrelin as a therapeutic approach for gastrointestinal motility disorders.
    Peeters TL
    Curr Opin Pharmacol; 2006 Dec; 6(6):553-8. PubMed ID: 17011824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does domperidone potentiate mirtazapine-associated restless legs syndrome?
    Chang CC; Shiah IS; Chang HA; Mao WC
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):316-8. PubMed ID: 16309808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of omeprazole on pharmacokinetics of domperidone given as free base and maleate salt in healthy Chinese patients.
    Zhang YF; Chen XY; Dai XJ; Zhang YN; Liu QZ; Yu HL; Zhong DF
    Acta Pharmacol Sin; 2007 Aug; 28(8):1243-6. PubMed ID: 17640489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders.
    Camilleri M; Bueno L; de Ponti F; Fioramonti J; Lydiard RB; Tack J
    Gastroenterology; 2006 Apr; 130(5):1421-34. PubMed ID: 16678556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of domperidone in human plasma by LC-MS and its pharmacokinetics in healthy Chinese volunteers.
    Wu MS; Gao L; Cai XH; Wang GJ
    Acta Pharmacol Sin; 2002 Mar; 23(3):285-8. PubMed ID: 11918857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacological and clinical characteristics of metoclopramide].
    Mosca S; D'Amato L; Gargiulo PL; Cautela G
    Clin Ter; 1981 May; 97(3):305-12. PubMed ID: 7026138
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacology of drugs acting on gastrointestinal motility].
    Van Nueten JM; Schuurkes JA
    Z Gastroenterol; 1988 Nov; 26 Suppl 4():4-8. PubMed ID: 3070983
    [No Abstract]   [Full Text] [Related]  

  • 36. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.
    Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; Ghatei MA; Bloom SR
    J Neuroendocrinol; 2000 Dec; 12(12):1213-8. PubMed ID: 11106980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of the functional disorders and motor disorders of the upper digestive tract with a new pharmacological preparation acting on the brain stem centers].
    Almeida Júnior N
    Hospital (Rio J); 1966 Oct; 70(4):863-82. PubMed ID: 5301842
    [No Abstract]   [Full Text] [Related]  

  • 38. Impaired gastric slow waves induced by spatial disorientation and effect of domperidone.
    Kono T; Tokumaru O; Mizumoto C; Tatsuno J; Chen JD
    Am J Gastroenterol; 1999 May; 94(5):1224-9. PubMed ID: 10235198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Motility-modifying drugs].
    Storr M; Allescher HD
    Internist (Berl); 2000 Dec; 41(12):1318-24, 1326-30. PubMed ID: 11189067
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experience with a new benzodiazepines derivative: the RO-5-3350 in fundamental functional diseases of the gastrointestinal system].
    Herrerias Gutierrez JM
    Rev Esp Enferm Apar Dig; 1974 May; 43(3):343-8. PubMed ID: 4839158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.